LA
NAVB
Lynch & Associates’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-18,000
| Closed | -$2K | – | 96 |
|
2019
Q1 | $2K | Hold |
18,000
| – | – | ﹤0.01% | 94 |
|
2018
Q4 | $2K | Hold |
18,000
| – | – | ﹤0.01% | 91 |
|
2018
Q3 | $4K | Hold |
18,000
| – | – | ﹤0.01% | 98 |
|
2018
Q2 | $4K | Hold |
18,000
| – | – | ﹤0.01% | 95 |
|
2018
Q1 | $6K | Hold |
18,000
| – | – | ﹤0.01% | 97 |
|
2017
Q4 | $6K | Hold |
18,000
| – | – | ﹤0.01% | 95 |
|
2017
Q3 | $7K | Hold |
18,000
| – | – | ﹤0.01% | 94 |
|
2017
Q2 | $9K | Hold |
18,000
| – | – | ﹤0.01% | 100 |
|
2017
Q1 | $10K | Hold |
18,000
| – | – | ﹤0.01% | 99 |
|
2016
Q4 | $11K | Hold |
18,000
| – | – | ﹤0.01% | 101 |
|
2016
Q3 | $16K | Hold |
18,000
| – | – | 0.01% | 107 |
|
2016
Q2 | $10K | Hold |
18,000
| – | – | ﹤0.01% | 109 |
|
2016
Q1 | $17K | Hold |
18,000
| – | – | 0.01% | 109 |
|
2015
Q4 | $24K | Hold |
18,000
| – | – | 0.01% | 106 |
|
2015
Q3 | $41K | Hold |
18,000
| – | – | 0.02% | 103 |
|
2015
Q2 | $29K | Hold |
18,000
| – | – | 0.02% | 106 |
|
2015
Q1 | $29K | Hold |
18,000
| – | – | 0.02% | 104 |
|
2014
Q4 | $34K | Hold |
18,000
| – | – | 0.02% | 95 |
|
2014
Q3 | $24K | Hold |
18,000
| – | – | 0.01% | 95 |
|
2014
Q2 | $27K | Hold |
18,000
| – | – | 0.02% | 89 |
|
2014
Q1 | $33K | Hold |
18,000
| – | – | 0.02% | 94 |
|
2013
Q4 | $37K | Hold |
18,000
| – | – | 0.02% | 93 |
|
2013
Q3 | $48K | Hold |
18,000
| – | – | 0.03% | 94 |
|
2013
Q2 | $48K | Buy |
+18,000
| New | +$48K | 0.03% | 95 |
|